Innovation Pharmaceuticals Inc (IPIX)

[loanranger]

"The primary measure of success for a drug in a Phase 2 is whether the drug proves efficacious for the specific disease or condition for which it is being evaluated. Brilacidin has succeeded in every Phase 2 trial to date."

Yet not a Phase 3 to be seen. And the only proceeds generated from all of those Phase 2s has been $400K.


"And based on that previous success and the very positive lab results, there is certainly reason to be optimistic that this Phase 2 trial against Covid will also succeed."